- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Korro Bio Inc (KRRO)
Korro Bio Inc stock price live, this page displays NASDAQ KRRO stock exchange data. View the KRRO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Korro Bio Inc real time stock price chart below.
What Is the Korro Bio Inc Stock Price Today?
The Korro Bio Inc stock price today is 13.280.
What Is the Stock Symbol for Korro Bio Inc?
The stock symbol for Korro Bio Inc is "KRRO."
What Stock Exchange Does Korro Bio Inc Trade On?
Korro Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Korro Bio Inc a Good Stock to Buy?
Determining whether Korro Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KRRO quote. (ISIN: US5009461089)
What Is the Korro Bio Inc Stock Price Today?
The Korro Bio Inc stock price today is 13.280.
What Is the Stock Symbol for Korro Bio Inc?
The stock symbol for Korro Bio Inc is "KRRO."
What Stock Exchange Does Korro Bio Inc Trade On?
Korro Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Korro Bio Inc a Good Stock to Buy?
Determining whether Korro Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KRRO quote. (ISIN: US5009461089)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.720
13.340
52 wk Range
5.204
55.890
KRRO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.72013.340
52 wk Range
5.20455.890
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KRRO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
20.200
Upside
+52.11%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
Form 4 Korro Bio Inc For: 17 July- Investing.com
Form 4 Korro Bio Inc For: 7 July- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Analyst Ratings
10 Buy
1 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 20.200
(+52.11% Upside)
Korro Bio Inc SWOT Analysis
RNA Editing Pionee | Korro Bio leads in RNA editing technology, with KRRO-110 for AATD treatment. Explore the potential of this groundbreaking approach in genetic disorders. |
Clinical Milestones | Delve into KRRO-110's Phase 1/2a REWRITE study. Learn about upcoming data releases and their potential impact on Korro Bio's market valuation. |
Financial Outlook | Discover Korro Bio's strategic moves to extend cash runway. Analysts set price targets ranging from $74 to $180, reflecting varied market expectations. |
Market Positioning | Uncover Korro Bio's competitive edge in the AATD treatment landscape. Examine the company's potential to revolutionize multiple therapeutic areas. |
Earnings
Latest Release
Aug 06, 2026
EPS / Forecast
-1.07 / -1.31
Revenue / Forecast
1.5M / 507.44K
Compare KRRO to Peers and Sector
Metrics to compare | KRRO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKRROPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −1.6x | −0.4x | |
PEG Ratio | −0.20 | −0.02 | 0.00 | |
Price/Book | 1.9x | 1.7x | 2.6x | |
Price / LTM Sales | 82.1x | 16.9x | 3.1x | |
Upside (Analyst Target) | 61.9% | 863.5% | 47.8% | |
Fair Value Upside | Unlock | 12.0% | 6.2% | Unlock |
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company’s lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson’s disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Korro Bio (KRRO) Stock Price Today?
The Korro Bio stock price today is 13.280 USD.
What Stock Exchange Does Korro Bio Trade On?
Korro Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Korro Bio?
The stock symbol for Korro Bio is "KRRO."
What Is the Korro Bio Market Cap?
As of today, Korro Bio market cap is 195.700M USD.
What Is Korro Bio's Earnings Per Share (TTM)?
The Korro Bio EPS (TTM) is -8.876.
When Is the Next Korro Bio Earnings Date?
Korro Bio will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is KRRO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Korro Bio Stock Split?
Korro Bio has split 0 times.
How Many Employees Does Korro Bio Have?
Korro Bio has 57 employees.
What is the current trading status of Korro Bio (KRRO)?
As of Aug 15, 2026, Korro Bio (KRRO) is trading at a price of 13.280 USD, with a previous close of 13.290 USD. The stock has fluctuated within a day range of 12.720 USD to 13.340 USD, while its 52-week range spans from 5.204 USD to 55.890 USD.
What Is Korro Bio (KRRO) Price Target According to Analysts?
The average 12-month price target for Korro Bio is 20.200 USD, with a high estimate of 30 USD and a low estimate of 10 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +52.11% Upside potential.
What Is the KRRO Premarket Price?
KRRO's last pre-market stock price is 13.350 USD. The pre-market share volume is 20.000, and the stock has decreased by 0.060, or 0.450%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.